Get An Early Start! (opens in new tab)

Here’s an oddity that I’m glad was put to the test of a controlled trial. It seems that retrospective studies on cancer immunotherapy patients had suggested that there might be an advantage to giving the infusions earlier in the day, so this team took 210 non-small-cell lung cancer patients and divided them into two groups. One got the infustion early in the day (from 7:30 AM to 2 PM), and the other later (from 3 PM to 8 PM). Some of the patients were taking sintilimab and others pembrolizuma...